SNAP29

Synaptosomal-associated protein 29 · O95721 · SNAP29 on Sugi Atlas →

0 patent compounds predicted against SNAP29, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SNAP29 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Ketamine Treatment Effects on Synaptic Plasticity in Depression PHASE4COMPLETED
Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle PHASE2/PHASE3NOT_YET_RECRUITING
Minocycline for the Treatment of Early-Phase Schizophrenia PHASE3COMPLETED
Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study PHASE2UNKNOWN
The Synapse Project PHASE2COMPLETED
Nilotinib in Huntington's Disease PHASE1UNKNOWN
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy EARLY_PHASE1ACTIVE_NOT_RECRUITING
Mechanisms of Vasovagal Syncope EARLY_PHASE1COMPLETED
Combined Aerobic Exercise and Cognitive Training in Seniors at Increased Risk for Alzheimer's Disease nanNOT_YET_RECRUITING
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices nanACTIVE_NOT_RECRUITING
Neurophysiologic Biomarkers in Rett Syndrome nanRECRUITING
Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy nanUNKNOWN
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
miR-142-3p as Potential Biomarker of Synaptopathy in MS nanUNKNOWN
Familial Aggregation and Biomarkers in REM Sleep Behaviour Disorder. nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging nanNOT_YET_RECRUITING
Study of Chediak-Higashi Syndrome nanRECRUITING
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort nanRECRUITING
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) nanNOT_YET_RECRUITING
Synaptic Injury and Functional Connectivity in Alzheimer's Disease nanCOMPLETED
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Serum Biomarkers in Parkinson's Disease at Different Stages nanRECRUITING
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs. nanENROLLING_BY_INVITATION
Sleep Homeostasis in Parkinson's Disease nanCOMPLETED
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Sensorimotor Gating in Schizophrenia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SNAP29 binder may also engage these)

ProteinNameSimilarity
Q5R5K4 1.000 Q5R5K4 →
Q0II86 1.000 Q0II86 →
Q9Z2P6 1.000 Q9Z2P6 →
Q9ERB0 0.999 Q9ERB0 →
Q0E1I7 0.986 Q0E1I7 →
Q9S7P9 0.984 Q9S7P9 →
Q9LMG8 0.976 Q9LMG8 →
Q9LRP1 0.975 Q9LRP1 →
P83351 0.975 P83351 →
Q9LNH6 0.975 Q9LNH6 →
SNAP23 Synaptosomal-associated protein 23 0.970 landscape →
Q9SD96 0.969 Q9SD96 →
Q944A9 0.968 Q944A9 →
P58200 0.965 P58200 →
O09044 0.962 O09044 →
Q752V4 0.961 Q752V4 →
P36976 0.960 P36976 →
Q2KIU0 0.960 Q2KIU0 →
Q9UEU0 0.959 Q9UEU0 →
O74786 0.958 O74786 →
O70377 0.958 O70377 →
Q8VDS8 0.957 Q8VDS8 →
Q9LVP9 0.956 Q9LVP9 →
Q4VBI7 0.956 Q4VBI7 →
Q5E9Y2 0.956 Q5E9Y2 →
Q6CSD1 0.956 Q6CSD1 →
Q9ZSD4 0.955 Q9ZSD4 →
P56962 0.955 P56962 →
Q9LK09 0.954 Q9LK09 →
Q9CQ56 0.954 Q9CQ56 →